What is the maximum recommended dose of Venofer (iron sucrose)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Venofer (Iron Sucrose)

The maximum recommended single dose of Venofer (iron sucrose) is 200 mg, with a maximum weekly dose of 500 mg according to FDA guidelines. 1

Dosing Guidelines for Iron Sucrose

  • The concentration of elemental iron in Venofer is 20 mg/ml 1
  • For single dose administration:
    • Maximum single dose: 200 mg 1
    • Minimum infusion time for maximum dose: 15 minutes (FDA) 1
    • Minimum injection time for maximum dose: 2-5 minutes (FDA) 1
  • For weekly dosing:
    • Maximum weekly dose: 500 mg 1
    • Individual doses above 300 mg are not recommended 1

Administration Methods

  • Iron sucrose can be administered by:
    • IV infusion: 200 mg over 60 minutes 1
    • IV push: 200 mg over 2-5 minutes 1
    • Repeated dosing every 2-3 weeks 1

Safety Considerations

  • Test doses are not required for iron sucrose, unlike iron dextran 1
  • However, test doses (25 mg slow IV push) are strongly recommended if patients have:
    • Previous sensitivities to iron dextran or other IV iron preparations 1
    • Multiple drug allergies 1
  • Patients with active infection should not receive IV iron therapy 1

Evidence for Dose Limitations

  • Studies have demonstrated that higher doses can lead to adverse events:
    • A 500 mg dose administered over 2 hours resulted in adverse reactions in 8 of 22 patients (36%), including dizziness, hypotension, and nausea 2
    • A 400 mg dose over 2 hours caused hypotension, nausea, and lower back pain in 2 of 35 patients 2
    • Doses of 200 mg and 300 mg administered over 2 hours were found to be safe with no adverse reactions 2

Clinical Applications

  • For treatment of iron deficiency in hemodialysis patients:
    • A common regimen is 100 mg IV during 10 consecutive hemodialysis sessions (replacement regimen) 3
    • For maintenance therapy: 100 mg IV weekly for 10 weeks 3
  • In cancer patients receiving ESAs:
    • Individual doses above 300 mg are not recommended 1
    • Maximum total dose = 1000 mg 1

Important Considerations

  • Iron sucrose has been shown to be effective and safe when administered within recommended dosing parameters 3, 4
  • The safety profile is favorable compared to some other IV iron preparations, particularly in patients with previous iron dextran sensitivity 4
  • Exceeding recommended doses significantly increases the risk of adverse events including hypotension, nausea, dizziness, and back pain 2

Remember that while higher single doses (300-500 mg) have been studied, the official FDA-approved maximum single dose remains 200 mg with a maximum weekly dose of 500 mg 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous iron sucrose: establishing a safe dose.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Research

Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.